TL;DR
This study reveals that dietary flaxseed oil, rich in alpha-linolenic acid (ALA), can significantly ameliorate atherosclerosis in mice. The protective effects are mediated through a complex interplay between the gut microbiota, reduced inflammation, and improved artery health, highlighting a promising dietary intervention for this cardiovascular disease.
What Problem Does This Paper Address?
Atherosclerosis (AS), a chronic inflammatory disease characterized by plaque buildup in arteries, is a leading cause of cardiovascular disease and mortality worldwide. While chronic low-grade inflammation and gut dysbiosis (imbalance in gut bacteria) are known contributors to AS, the precise mechanisms and effective interventions remain areas of active research. Flaxseed oil (FO), a rich source of omega-3 polyunsaturated fatty acids like ALA, has shown general health benefits, but its specific impact on AS and the underlying pathways were not well understood. This paper aims to elucidate how dietary ALA-rich FO influences AS development and to identify the key molecular and microbial players involved.
Methods
The researchers employed a multi-faceted approach using ApoE-/- mice, a common model for studying atherosclerosis due to their genetic predisposition to developing arterial lesions.
- Animal Models: Two main experimental phases were conducted:
- Phase 1: ApoE-/- mice were fed a normal diet (CON), a high-fat diet (MOD) to induce AS, or a high-fat diet supplemented with flaxseed oil (MOD/FO) for 12 weeks.
- Phase 2: To investigate the role of gut microbiota, a subset of mice received an antibiotic (AB) cocktail to disrupt their gut flora. These mice were then divided into AB-treated model (AB/MOD) and AB-treated model with FO (AB/FO) groups.
- Histological Analysis: Aortic tissues were stained (Oil Red O, Hematoxylin & Eosin, Masson's trichrome) to visualize and quantify atherosclerotic lesions and plaque composition.
- Biochemical Assays: Plasma levels of total bile acids (TBA) and lipopolysaccharide (LPS) were measured.
- Cytokine Profiling: Cytometric Bead Array (CBA) was used to quantify pro- and anti-inflammatory cytokines in plasma and aortic tissues.
- Flow Cytometry & Immunofluorescence: Macrophages (Mψs), key inflammatory cells in AS, were identified and quantified in aortic tissues using specific antibodies.
- Gut Microbiota Analysis: 16S rRNA gene sequencing was performed on fecal samples to analyze the composition and diversity of the gut microbiome.
- Metabolomics: Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were used to quantify short-chain fatty acids (SCFAs) and bile acids (BAs) in fecal samples, respectively.
- Correlation Analysis: Statistical methods were used to explore relationships between gut bacteria, metabolites, inflammatory markers, and AS progression.
Datasets
Not explicitly discussed as distinct datasets in the paper. The study generated its own data through the experimental procedures described above. Fecal microbial 16S rRNA gene sequencing data was submitted to the NCBI's Sequence Read Archive (SRA) under accession number PRJNA624814.
Key Insights and Ideas
- The Gut-Microbiota-Inflammation-Artery Axis is Key: The most significant finding is the demonstration that dietary ALA-rich FO ameliorates AS not just by directly impacting the artery but by orchestrating a complex response involving the gut microbiota and systemic inflammation.
- Antibiotics Undermine FO's Benefits: The fact that FO's protective effects were significantly weakened in antibiotic-treated mice strongly suggests that the gut microbiota is crucial for mediating these benefits. This is a powerful piece of evidence for the gut-centric mechanism.
- FO Modulates Gut Bacteria and Metabolites: ALA-rich FO demonstrably altered the gut microbial community, shifting the Firmicutes/Bacteroidetes ratio and regulating specific bacterial genera. It also influenced the production of beneficial SCFAs and modulated bile acid profiles.
- Reduced LPS is a Critical Link: FO treatment led to a significant decrease in plasma LPS, a potent pro-inflammatory molecule originating from gut bacteria. This suggests FO improves gut barrier integrity, preventing LPS translocation and subsequent inflammation.
- Anti-inflammatory Macrophages: FO intervention reduced the infiltration and activation of inflammatory macrophages in atherosclerotic lesions, a critical step in AS progression.
Key Results
- Reduced Atherosclerotic Lesions: Flaxseed oil significantly reduced atherosclerotic lesion area in the aorta and aortic sinus compared to the high-fat diet group.
- Improved AS Parameters: Body weights and total bile acid (TBA) levels were favorably modulated by FO treatment.
- Decreased Inflammation: Plasma and aortic levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17A) were significantly reduced by FO. In situ macrophages in aortic lesions were also decreased.
- Enhanced Gut Integrity: Plasma LPS levels were significantly lowered in FO-treated mice, indicating improved gut barrier function.
- Gut Microbiota Modulation: FO treatment altered the gut microbial community structure and shifted the Firmicutes/Bacteroidetes ratio. It also increased beneficial SCFAs (acetic acid, propionic acid, isovaleric acid, isobutyric acid, valeric acid) and modulated bile acid profiles.
- Antibiotic Impact: In antibiotic-treated mice, the beneficial effects of FO on AS were significantly attenuated, highlighting the critical role of the gut microbiota.
Limitations and Future Work
- Mechanism of Macrophage Modulation: While FO reduced inflammatory macrophages, the exact molecular mechanism by which it suppresses Mψ polarization needs further investigation.
- Gut Microbiota-Independent Effects: The study acknowledges that FO might have some anti-inflammatory effects independent of gut microbiota modulation, suggesting further research into direct molecular targets like G-protein coupled receptors (GPRs).
- Specific Bacterial Roles: While differential bacteria were identified, their precise roles in the FO-mediated AS amelioration require deeper exploration.
- Human Translation: The study was conducted in mice, and further research is needed to confirm these findings and their applicability in human populations.
- Detailed Metabolite Pathways: While SCFAs and BAs were analyzed, a more in-depth understanding of how these metabolites interact with specific receptors and signaling pathways in AS is warranted.
Summary updated